EGFR aberrations activate multiple downstream pro-oncogenic signaling pathways and subsequently induce biological processes that are beneficial to cancer maintenance and progression, including chronic initiation, metabolic regulation, and cell-cycle regulation [58]. The gene discussed is EGFR; the disease is cancer.